{"prompt": "['Alliance A171601', '125', 'Nam EJ, Kim YT. Alteration of cell-cycle regulation in epithelial ovarian cancer. Int J Gynecol', 'Cancer. 2008 Nov-Dec;18(6):1169-82. doi:10.1111/j.1525-1438.2008.01191.x.Review. PubMed', 'PMID: 18298566.', '126', 'Canavese M, Santo L, Raje N. Cyclin dependent kinases in cancer: potential for therapeutic', 'intervention. Cancer Biol Ther.2012 May;13(7):451-7.doi:10.4161/cbt.19589.Review. PubMed', 'PMID: 22361734.', '127', 'Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J: Cyclin D1 protein expression and', 'function in human breast cancer. Int J Cancer 1994, 57:353-361.', '128', 'Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G: Amplification and', 'overexpression of cyclin D1 in breast cancer detected by immunohistochemica staining. Cancer', 'Res 1994, 54:1812-1817.', '129 Kenny FS, Hui R, Musgrove EA, Gee JM, Blamey RW, Nicholson RI, Sutherland RL, Robertson', 'JF: Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-', 'positive breast cancer. Clin Cancer Res 1999, 5:2069-2076.', '130', 'Hwang TS, Han HS, Hong YC, Lee HJ, Paik NS: Prognostic value of combined analysis of cyclin', 'D1 and estrogen receptor status in breast cancer patients. Pathol Int 2003, 53:74-80.', '131', 'Rudas M, Lehnert M, Huynh A, Jakesz R, Singer C, Lax S, et al: Cyclin D1 expression in breast', 'cancer patients receiving adjuvant tamoxifen-based therapy. Clin Cancer Res 2008, 14:1767-1774.', '132', 'Jirstrom K, Stendahl M, Ryden L, Kronblad A, Bendahl PO, Stal O, Landberg G: Adverse effect', 'of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification. Cancer', 'Res 2005, 65:8009-8016.', '133', 'Fry DW, Harvey PJ, Keller PR, Elliott WL, Meade M, Trachet E, et al: Specific inhibition of fcyclin-', 'dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts.', 'Mol Cancer Ther 2004, 3:1427-1438.', '134', 'Toogood PL, Harvey PJ, Repine JT, Sheehan DJ, Vander Wel SN, et al: Discovery of a potent and', 'selective inhibitor of cyclin-dependent kinase 4/6. JMed Chem 2005, 48:2388-2406.', '135', 'Marzec M, Kasprzycka M, Lai R, Gladden AB, et al: Mantle cell lymphoma cells express', 'predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase', 'activity. Blood 2006, 108:1744-1750.', '136', 'Saab R, Bills JL, Miceli AP, Anderson CM, et al: Pharmacologie inhibition of cyclin-dependent', 'kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells. Mol', 'Cancer Ther 2006, 5:1299-1308.', '137', 'Baughn LB, Di Liberto M, Wu K, Toogood PL, Louie T, Gottschalk R, et al: A novel orally active', 'small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by', 'specific inhibition of cyclin-dependent kinase 4/6. Cancer Res 2006, 66:7661-7667.', '138', 'Deng Q, Guo H, DaiJ, Yang L, Wu C, Wang Q, Hu Z, et al: Imputation-based association analyses', 'identify new lung cancer susceptibility variants in CDK6 and SH3RF1 and their interactions with', 'smoking in Chinese populations. Carcinogenesis. 2013 Sep;34(9):2010-6.', 'doi:', '10.1093/carcin/bgt145. PubMed PMID: 23644744.', '139', 'Ye Y, Yang H, Grossman HB, Dinney C, Wu X, Gu J. Genetic variants in cell cycle control', 'pathway confer susceptibility to bladder cancer. Cancer. 2008 [un;112(11):2467-74. doi:', '10.1002/cncr.23472. PubMed PMID: 18361427.', '140.', 'Kibel AS, Ahn J, Isikbay M, Klim A, Wu WS, Hayes RB, Isaacs WB, Daw EW. Genetic variants', 'in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma. Prostate. 2016', 'Apr;76(5):479-90. doi:10.1002/pros.23139.PubMed PMID: 26708993', '141.', 'Driver KE, Song H, Lesueur F, Ahmed S, Barbosa-Morais NL, Tyrer JP, et al: Studies in', 'Epidemiology and Risks of Cancer Heredity (SEARCH) Team Association of single-nucleotide', 'polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis.', '2008 Feb;29(2):333-41. doi: 10.1093/carcin/bgm284.PubMed PMID:1 18174243; PubMed Central', 'PMCID: PMC2346546.', '84', 'NCIVersion Date: 5/29/2020', 'Update 5']['Alliance A171601', '142.', 'Goode EL, Fridley BL, Vierkant RA, Cunningham JM, et al: Candidate gene analysis using', 'imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Cancer', 'Epidemiol Biomarkers Prev. 2009 Mar;18(3):935-44. doi: 10.1158/1055-9965.EPI-08-0860.', 'PubMed PMID: 19258477; PubMed Central PMCID: PMC2743184.', '143.', 'Cai H, Xiang YB, Qu S, Long J, Cai Q, Gao J, Zheng W, Shu XO. Association of genetic', 'polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese', 'women. Am J Epidemiol. 2011 Jun 1;173(11):1263-71. doi: 10.1093/aje/kwr002. PubMed PMID:', '21454826; PubMed Central PMCID: PMC3101066.', '144.', 'Campa D, Pastore M, Gentiluomo M, Talar-Wojnarowska R, et al:. Functional single nucleotide', 'polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer', 'risk. Oncotarget. 2016 Aug 30;7(35):57011-57020. doi:10.18632/oncotarget.10935. PubMed', 'PMID: 27486979; PubMed CentralPMCID:PMC5302969', '145.', 'Cacina C, Yaylim-Eraltan I, Arikan S, Saglam EK, Zeybek U, Isbir T. Association between', 'CDKN1A Ser31Arg and C20T gene polymorphisms and colorectal cancer risk and prognosis. In', 'Vivo. 2010 Mar-Apr;24(2):179-83. PubMed PMID:20363991.', '146.', 'Schondorf T, Eisele L, Gohring UJ, Valter MM, et al : The V109G polymorphism of the p27 gene', 'CDKN1B indicates a worse outcome in node-negative breast cancer patients. Tumour Biol. 2004,', '25: 306-312. 10.1159/000081396. PubMed PMID: 15627896.', '147.', 'Azzato EM, Driver KE, Lesueur F, Shah M, et al : Effects of common germline genetic variation', 'in cell cycle control genes on breast cancer survival: results from a population-based cohort. Breast', 'Cancer Res. 2008;10(3):R47. doi: 10.1186/bcr2100. PubMed PMID: 18507837; PubMed Central', 'PMCID: PMC2481496.', '148.', 'Driver KE, Song H, Lesueur F, Ahmed S, Barbosa-Morais NL, Tyrer JP, Ponder BA, Easton DF,', 'Pharoah PD, Dunning AM; Studies in Epidemiology and Risks of Cancer Heredity (SEARCH)', 'Team Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer', 'in the British population. Carcinogenesis. 2008 Feb;29(2):333-41. doi: 10.1093/carcin/bgm284.', 'PubMed MID:18174243; PubMed Central PMCID: PMC2346546.', '149.', 'Shu XO, Moore DB, CaiQ, Cheng J, Wen W, Pierce L, CaiH, Gao YT, Zheng W: Association of', 'cyclin D1 genotype with breast cancer risk and survival. Cancer Epidemiol Biomarkers Prev. 2005,', '14: 91-97. PubMed PMID: 15668481.', '150.', 'Soleimani Z, Kheirkhah D, Sharif MR Sharif A, Karimian M, Aftabi Y. Association of CCND1', 'Gene c.870G>A Polymorphism with Breast Cancer Risk: A Case-ControlStudy and a Meta-', 'Analysis. Pathol Oncol Res. 2016 Dec 21. oi:10.1007/s12253-016-0165-3. [Epub ahead of print]', 'PubMed PMID: 28004353.', '151.', 'Yaylim-Eraltan I, Ergen A, G\u00f6rm\u00fcs U, Arikan S, K\u00fci\u00e7\u00fcc\u00fck S, Sahin O, Yigit N, Yildiz Y, Isbir T.', 'Breast cancer and cyclin D1 gene polymorphism in Turkish women. In Vivo. 2009 Sep-', 'Oct;23(5):767-72. PubMed PMID: 19779113.', '152.', 'Bewick MA, Conlon MS, Lafrenie RM. Polymorphisms in XRCC1, XRCC3, and CCND1 and', 'survival after treatment for metastatic breast cancer. J Clin Oncol. 2006 Dec 20;24(36):5645-51.', 'PubMed PMID: 17116943.', '153.', 'Zhou LP, Yao F, Luan H, Wang YL, Dong XH, Zhou WW, Wang QH. YP3A4*1Bpolymorphism', 'and cancer risk: a HuGE review and meta-analysis. Tumour Biol. 2013 Apr;34(2):649-60. doi:', '10.1007/s13277-012-0592-z. Review. PubMed PMID: 23179402.', '154.', 'Johnson N, Dudbridge F, Orr N, Gibson L, Jones ME, Schoemaker MJ, et al. Genetic variation at', 'CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Breast', 'Cancer Res. 2014 May 26;16(3) R51. doi: 10.1186/bcr3662. PubMed PMID: 24887515; PubMed', 'Central PMCID: PMC4522594.', '85', 'NCIVersion Date: 5/29/2020', 'Update 5']\n\n###\n\n", "completion": "END"}